| 000 | 01298 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517105018.0 | ||
| 264 | 0 | _c20180405 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2016.06.043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArends, Tom J H | |
| 245 | 0 | 0 |
_aReply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52. _h[electronic resource] |
| 260 |
_bEuropean urology _c01 2017 |
||
| 300 |
_ae31-e32 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 | _aBCG Vaccine |
| 650 | 0 | 4 | _aBacillus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMitomycin |
| 650 | 0 | 4 | _aUrinary Bladder Neoplasms |
| 700 | 1 | _aWitjes, J Alfred | |
| 773 | 0 |
_tEuropean urology _gvol. 71 _gno. 1 _gp. e31-e32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2016.06.043 _zAvailable from publisher's website |
| 999 |
_c26235403 _d26235403 |
||